共 50 条
- [31] Selective histone deacetylase (HDAC) inhibition imparts beneficial effects in Huntingtons disease mice: implications for the ubiquitinproteasomal and autophagy systems[J]. HUMAN MOLECULAR GENETICS, 2012, 21 (24) : 5280 - 5293Jia, HaiqunKast, Ryan J.Steffan, Joan S.Thomas, Elizabeth A.
- [32] Novel and selective inhibitors of histone deacetylases (HDAC) 1 and 2 significantly enhance the activity of the DNA methyltransferase inhibitor azacitidine in acute myeloid leukemia (AML)[J]. CANCER RESEARCH, 2015, 75Min, ChengyinQuayle, Steven N.Tamang, DavidJones, Simon S.Yang, Min
- [33] Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (46) : 20003 - 20008Namdar, MandanaPerez, GiselaNgo, LangMarks, Paul A.
- [34] Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (22) : 10000 - 10016Marek, MartinShaik, Tajith B.Heimburg, TinoChakrabarti, AloktaLancelot, JulienRamos-Morales, ElizabethDa Veiga, CyrielleKalinin, DmitriiMelesina, JelenaRobaa, DinaSchmidtkunz, KarinSuzuki, TakayoshiHoll, RalphEnnifar, EricPierce, Raymond J.Jung, ManfredSippl, WolfgangRomier, Christophe
- [35] Methionine 274 Is Not the Determining Factor for Selective Inhibition of Histone Deacetylase 8 (HDAC8) by L-Shaped Inhibitors[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (19)Jansch, NiklasLang, Kim LeoniMeyer-Almes, Franz-Josef
- [36] Identification of Novel, Selective, and Stable Inhibitors of Class II Histone Deacetylases. Validation Studies of the Inhibition of the Enzymatic Activity of HDAC4 by Small Molecules as a Novel Approach for Cancer Therapy[J]. JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (21) : 6782 - 6789Ontoria, Jesus M.Altamura, SergioDi Marco, AnnaliseFerrigno, FedericaLaufer, RalphMuraglia, EsterPalumbi, Maria CeciliaRowley, MichaelScarpelli, RitaSchultz-Fademrecht, CarstenScrafini, SergioSteinkuehler, ChristianJones, Philip
- [37] Chimerically designed HDAC- and tyrosine kinase inhibitors. A series of erlotinib hybrids as dual-selective inhibitors of EGFR, HER2 and histone deacetylases[J]. MEDCHEMCOMM, 2012, 3 (07) : 829 - 835Beckers, ThomasMahboobi, SiavoshSellmer, AndreasWinkler, MatthiasEichhorn, EmerichPongratz, HerwigMaier, ThomasCiossek, ThomasBaer, ThomasKelter, GerhardFiebig, Heinz-HerbertSchmidt, Mathias
- [38] Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout br[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2022, 144 (41) : 18861 - 18875Steimbach, Raphael R.Herbst-Gervasoni, Corey J.Lechner, SeverinStewart, Tracy MurrayKlinke, GlynisRidinger, JohannesGeraldy, Magalie N. E.Tihanyi, GergelyFoley, Jackson R.Uhrig, UlrikeKuster, BernhardPoschet, GernotCasero, Robert A., Jr.Medard, GuillaumeOehme, InaChristianson, David W.Gunkel, NikolasMiller, Aubry K.
- [39] Identification of Molecular Interactions within Histone Deacetylase Isozymes for the Development of Selective HDAC2 Inhibitors for the Design of Targeted Cancer Therapies[J]. FASEB JOURNAL, 2017, 31May, XavierWatkins, DavitaStoddard, Shana V.
- [40] Discovery of novel isoform-selective histone deacetylases 5 and 9 inhibitors through combined ligand-based pharmacophore modeling, molecular mocking, and molecular dynamics simulations for cancer treatment[J]. JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2021, 106Elmezayen, Ammar D.Al-Obaidi, AnasYelekci, Kemal